Deregulated expression of KRAP, a novel gene encoding actin-interacting protein, in human colon cancer cells

Journal of Human Genetics

Volumn 49, Issue 1, 2004, Pages 46-52

  Inokuchi, Junichi ^a,b   Komiya, Misako ^a   Baba, Iwai ^a   Naito, Seiji ^b   Sasazuki, Takehiko ^a   Shirasawa, Senji ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Actin filaments; Cancer; CS 1; Ki ras; KRAP

Indexed keywords

ACTIN; COMPLEMENTARY DNA; CYTOCHALASIN E; GENE PRODUCT; KI RAS INDUCED ACTIN INTERACTING PROTEIN; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ACTIN FILAMENT; AMINO ACID SEQUENCE; ARTICLE; CANCER CELL CULTURE; COLON CARCINOMA; COLON MUCOSA; CONTROLLED STUDY; DNA LIBRARY; EXTRACELLULAR SPACE; GENE CONTROL; GENE EXPRESSION; GENETIC CODE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; KRAP GENE; MEMBRANE BINDING; MOLECULAR SIZE; NUCLEOTIDE SEQUENCE; ONCOGENE K RAS; PANCREAS; PROTEIN LOCALIZATION; TESTIS; UPREGULATION;

AMINO ACID SEQUENCE; BIOTINYLATION; BLOTTING, NORTHERN; CYTOCHALASINS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENE LIBRARY; GENES, RAS; HCT116 CELLS; HUMANS; MALE; MEMBRANE PROTEINS; MICROFILAMENT PROTEINS; MOLECULAR SEQUENCE DATA; PANCREAS; PRECIPITIN TESTS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; TESTIS; TRANSFECTION;

EID: 0442293930     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-003-0106-3     Document Type: Article

References (22)

1. Allgayer H, Wang H, Shirasawa S, Sasazuki T, Boyd D (1999) Targeted disruption in an invasive colon cancer cell line downregulates urokinase receptor expression and plasminogen-dependent proteolysis. Brit J Cancer 80:1884-1891
2. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M (1998) Most human carcinomas of the exocrine pancreas contain mutant c-Ki-ras genes. Cell 53:549-554
3. Baba I, Shirasawa S, Iwamoto R, Okumura K, Tsunoda T, Nishioka M, Fukuyama K, Yamamoto K, Mekada E, Sasazuki T (2000) Involvement of deregulated epiregulin expression in tumorigenesis in vivo through activated Ki-Ras signaling pathway in human colon cancer cells. Cancer Res 60:6886-6889
4. Barbacid M (1987) ras genes. Annu Rev Biochem 56:779-827
5. Bos JL (1989) ras oncogene in human cancer: a review. Cancer Res 49:4682-4689
6. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom J, van der Eb AJ, Vogelstein B (1987) Prevalence of ras gene mutations in human colorectal cancers. Nature 327:293-297
7. Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ, Der CJ (1998) Increasing complexity of Ras signaling. Oncogene 17:1395-1413
8. Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M (1987) Detection of high incidence of Ki-ras oncogene during human colon tumorigenesis. Nature 327:298-303
9. Javed AA, Naz RK (1992) Human cleavage signal-1 protein; cDNA cloning transcription and immunological analysis. Gene 112:205-211
10. Johnson L, Greenbaum D, Cichowski K, Mercer K, Murphy E, Schmitt E, Bronson RT, Umanoff H, Edelmann W, Kucherlapati R, Jacks T (1997) K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev 11:2468-2481
11. Nakamura H, Wu C, Kuang J, Larabell C, Etkin LD (2000) XCS-1, a maternally expressed gene product involved in regulating mitosis in Xenopus. J Cell Sci 113:2497-2505
12. Naz RK (1992) Effects of antisperm antibodies on early cleavage of fertilized ova. Biol Reprod 46:130-139
13. Okada F, Rak JW, Croix BS, Lieubeau B, Kaya M, Roncari L, Shirasawa S, Sasazuki T, Kerbel RS (1998) Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulated of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. Proc Natl Acad Sci USA 95:3609-3614
14. Okumura K, Shirasawa S, Nishioka M, Sasazuki T (1999) Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells. Cancer Res 59:2445-2450
15. Pollard TD (2003) The cytoskeleton, cellular motility and the reductionist agenda. Nature 422:741-745
16. Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T, Kerbel RS (1995) Mutant ras oncogene upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 55:4575-4580
17. Shirasawa S (1993) Analysis of molecular mechanism in colorectal tumorigenesis. Fukuoka Igaku Zasshi 84:25-35
18. Shirasawa S, Furuse M, Yokoyama N, Sasazuki T (1993) Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260:85-88
19. 2-terminal region of mig-6. Cancer Res 62:5668-5671
20. Udagawa T, Yuan J, Panigrahy D, Chang Y, Shah J, D'Amato RJ (2000) Cytochalasin E, an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor growth. J Pharmacol Exp Ther 294:421-427
21. Webb DJ, Parsons JT, Horwitz AF (2002) Adhesion assembly, disassembly and turnover in migrating cells-over and over and over again. Nat Cell Biol 4:E97-E100
22. Zuber J, Tchernitsa OI, Hinzmann B, Schmitz A-C, Grips M, Hellriegel M, Sers C, Rosenthal A, Schafer R (2000) A genomewide survey of RAS transformation targets. Nat Genet 24:144-152